Aselizumab (SELL/CD62L ) - Research Grade Biosimilar, Unconjugated, Monoclonal

Artikelnummer: PRS-10-287
Artikelname: Aselizumab (SELL/CD62L ) - Research Grade Biosimilar, Unconjugated, Monoclonal
Artikelnummer: PRS-10-287
Hersteller Artikelnummer: 10-287
Alternativnummer: PRS-10-287-0.1
Hersteller: ProSci
Kategorie: Antikörper
Immunogen: Humanized / SELL/CD62L [Homo sapiens]
Konjugation: Unconjugated
Alternative Synonym: HuDreg-55
Klonalität: Monoclonal
Konzentration: batch dependent
Puffer: PBS buffer pH7.5
Quelle: CHO cells
Application Verdünnung: Optimal dilutions for each application to be determined by the researcher.